BioLine RX News

News

Ticker

BLRX.TA

ISIN

IL0011015182

Omsætning Nettoindtægt P/E P/S EBIT Udbytte Insiderkøb Aktier Markedsværdi Gæld Forpligtelser Egenkapital AAQS Medarbejdere ROE ROA ROCE News Dokumenter

BioLine RX Eulerpool nyheder

BioLine RX Aktie Nyheder

BioLine RX bliver overvåget af journalister og investorer verden over. Vi samler de seneste BioLine RX nyheder her.

20. marts ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
26. februar ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
23. februar ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
29. november ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
25. november ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
24. november ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24. november ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
18. november ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
17. november ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
30. september ·
Yahoo
BLRX: A Venture into GBM

BioLine RX Aktie Pressemeddelelser

BioLine RX udgiver regelmæssigt nyheder på virksomhedens websted, der er relevante for investorer.

BioLine RX News 2026

Denne side indeholder alle aktuelle nyheder, analyser og pressemeddelelser for BioLine RX aktie (BLRX.TA, ISIN: IL0011015182). Dette omfatter Eulerpool-nyheder, virksomhedsanalyse og officielle pressemeddelelser. Data opdateres regelmæssigt for at give investorer et fuldstændigt overblik over de seneste udviklingen hos BioLine RX.

BioLine RX Aktie

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.